-
Introducing the Koning Vera
Koning manufactures the Koning Vera (also called Koning Vera Breast CT or KBCT), the latest version of our breast CT device. Vera introduces a less than 10 second scanning time per breast. It is a multifunctional device capable of 3D guided biopsy, and does so at radiation dose levels comparable to diagnostic mammography.
-
A Better Way of Breast Imaging
While mammography is a standard screening tool, it may not detect between 6% and 46% of breast cancers; these misses are often attributed to high breast density or fast-growing interval cancers according to the National Cancer Institute (NCI). For women with extremely dense breast tissue, cancer detection can drop significantly, with up to one-third or even half of cancers remaining undetected by mammography alone (American College of Radiology). However, early detection remains critical, as the five-year relative survival rate for localized breast cancer is approximately 99% (American Cancer Society and the National Breast Cancer Foundation).
-
The Difference is Clear
Learn more about the differences between Koning Vera Breast CT and diagnostic mammography.
-
Revolutionary breast imaging available worldwide
Koning Vera is Available Worldwide
The breast imaging industry is getting an upgrade with
Koning's advanced computed tomography technology
The Koning Vera (KBCT) is designed to provide clinicians with advanced 3D imaging of breast tissue, offering a new perspective in visualization and evaluation. By delivering high-resolution images without compression, the technology aims to support physicians in making more informed decisions across the continuum of care. Our goal is to expand access to tools that may enhance early detection, diagnosis, and treatment planning, with the ultimate vision of contributing to improved patient experiences and outcomes.
Statistics
Source: https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html
Breast cancer is more treatable with early detection
Five-year survival for stage 0-1 is 99%. In April 2025, it was reported by the National Cancer Institute (NCI) that the 5-year relative survival rate for breast cancer was 99% when diagnosed in the localized stage. This drops to 31% if it has spread to distant parts of the body. Also, it was reported by the NCI that invasive breast cancer can be undetected in 6% to 46% of examinations, often due to high breast density or perceptual errors. In addition, it has been reported within the educational review published by Insights into Imaging in January 2026 that between 10% and 30% of breast cancers are misdiagnosed or missed.
By design, the technology used within the Koning System allows for the identification of lesions as small as 2 mm and calcifications as small as 200 microns without breast compression. This allows the Radiologist to view breast tissue in true 3D slices from any angle, effectively eliminating the tissue superimposition (overlapping structures) that can often hide cancers in early stages.
What We Do
Koning has been developing cone-beam CT technology for over two decades. As the winner of multiple awards including the 2016 Frost and Sullivan New Innovation Award in Breast Imaging, and as holder of over 120 patents globally, Koning has developed technology to bring a better breast imaging solution to women around the world.
Each Output of a Scan is a 3D Image
Watch the Koning Vera scan in action
Koning Vera produces high-contrast real 3D images of the breast with exceptional spatial resolution, no painful compression, in less than 10 seconds of exposure, at radiation levels in the range of diagnostic mammograms.
Early detection improves intervention
Koning Vera in your city
The Koning Vera (KBCT) is designed to provide clinicians with advanced 3D imaging of breast tissue, offering a new perspective in visualization and evaluation. Currently available in several locations, our technology is expanding rapidly and we're working to get more devices in a city near you!
